- 作者：Daniel Ferná ; ndez-Bergé ; s<sup>asup><sup> ; sup><sup>polonibo@gmail.comsup> ; Antonio Cabrera de Leó ; n<sup>bsup><sup> ; sup><sup>csup> ; Hé ; ctor Sanz<sup>dsup> ; Roberto Elosua<sup>dsup><sup> ; sup><sup>esup> ; Marí ; a J. Guembe<sup>fsup><sup> ; sup><sup>gsup> ; Maite Alzamora<sup>hsup><sup> ; sup><sup>isup> ; Tomá ; s Vega-Alonso<sup>jsup> ; Francisco J. Fé ; lix-Redondo<sup>asup><sup> ; sup><sup>ksup> ; Honorato Ortiz-Marró ; n<sup>lsup> ; Fernando Rigo<sup>msup> ; Carmen Lama<sup>nsup><sup> ; sup><sup>osup> ; Diana Gavrila<sup>esup><sup> ; sup><sup>psup> ; Antonio Segura-Fragoso<sup>qsup> ; Luis Lozano<sup>asup> ; Jaume Marrugat<sup>dsup>
- 关键词：Metabolic syndrome ; Diabetes mellitus ; Cardiovascular disease ; Risk scores
- 刊名：Revista Española de Cardiología (English Edition)
- 出版年：2012
- 出版时间：March, 2012
- 年：2012
- 卷：65
- 期：3
- 页码：241-248
- 全文大小：274 K
ss=""h4"">Introduction and objectives
To update the prevalence of metabolic syndrome and associated coronary risk in Spain, using the harmonized definition and the new World Health Organization proposal (metabolic premorbid syndrome), which excludes diabetes mellitus and cardiovascular disease.ss=""h4"">Methods
Individual data pooled analysis study of 24 670 individuals from 10 autonomous communities aged 35 to 74 years. Coronary risk was estimated using the REGICOR function.
ss=""h4"">Results
Prevalence of metabolic syndrome was 31 % (women 29 % [95 % confidence interval, 25 % -33 % ], men 32 % [95 % confidence interval, 29 % -35 % ]). High blood glucose (P=.019) and triglycerides (P<.001) were more frequent in men with metabolic syndrome, but abdominal obesity (P<.001) and low high-density lipoprotein cholesterol (P=.001) predominated in women. Individuals with metabolic syndrome showed moderate coronary risk (8 % men, 5 % women), although values were higher (P<.001) than in the population without the syndrome (4 % men, 2 % women). Women and men with metabolic syndrome had 2.5 and 2 times higher levels of coronary risk, respectively (P<.001). Prevalence of metabolic premorbid syndrome was 24 % and the increase in coronary risk was also proportionately larger in women than in men (2 vs 1.5, respectively; P<.001).
ss=""h4"">Conclusions
Prevalence of metabolic syndrome is 31 % ; metabolic premorbid syndrome lowers this prevalence to 24 % and delimits the population for primary prevention. The increase in coronary risk is proportionally larger in women, in both metabolic syndrome and metabolic premorbid syndrome.